Quanterix Corporation

Equities

QTRX

US74766Q1013

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-20 pm EDT			5-day change	1st Jan Change
3.300 ^USD	-5.71%		-1.79%	-48.11%

Apr. 17	Preludedx and Quanterix Corporation Demonstrate Aidabreast Multi-Omic Assay for Early-Stage Invasive Breast Cancer	CI
Apr. 15	Quanterix Corporation Debuts Content Innovation Engine At AACR 2026	CI

Transcript : Quanterix Corporation, Q4 2025 Earnings Call, Mar 02, 2026

Published on 03/02/2026 at 05:11 pm EST - Modified on 03/03/2026 at 04:05 am EST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, thank you for standing by. My name is Colby, and I will be your conference operator today. At this time, I would like to welcome

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Quanterix Corporation

Apr. 17	Preludedx and Quanterix Corporation Demonstrate Aidabreast Multi-Omic Assay for Early-Stage Invasive Breast Cancer	CI
Apr. 15	Quanterix Corporation Debuts Content Innovation Engine At AACR 2026	CI
Mar. 02	Quanterix Corporation, Q4 2025 Earnings Call, Mar 02, 2026
Mar. 02	Quanterix Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
Mar. 02	Quanterix Provides Earnings Guidance for the Year 2026	CI
Mar. 02	Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide	CI
Feb. 03	Quanterix Files 510(k) With FDA for Alzheimer's Blood Test	MT
Feb. 03	Quanterix announces FDA 510(k) submission for a multi-analyte algorithmic blood test for Alzheimer’s disease detection	RE
Feb. 03	Quanterix Corporation Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer's Disease Detection	CI
Jan. 21	Quanterix Corporation Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer's Risk Profiling	CI
Jan. 08	Quanterix Names Everett Cunningham President and CEO	MT
Jan. 08	Quanterix Names Everett Cunningham President and CEO	MT
Jan. 08	Quanterix Corporation Announces Chief Executive Officer Changes, Effective January 19, 2026	CI
Jan. 08	Quanterix Corporation Announces Management Changes, Effective January 19, 2026	CI
Jan. 08	Quanterix appoints Everett Cunningham as president and CEO effective January 19, 2026	RE